Pharmarise Holdings Corporation (TYO:2796)

Pharmarise Holdings Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Cash & Equivalents	2,555	4,911	7,150	4,742	3,991	4,604
Cash & Short-Term Investments	2,555	4,911	7,150	4,742	3,991	4,604
Cash Growth	-66.04%	-31.31%	50.78%	18.82%	-13.31%	2.95%
Accounts Receivable	732	735	1,439	605	479	926
Other Receivables	3,117	3,050	2,117	3,412	3,786	2,159
Receivables	3,849	3,785	3,556	4,017	4,265	3,085
Inventory	4,678	4,146	2,645	2,290	2,302	2,587
Other Current Assets	478	397	386	323	320	270
Total Current Assets	11,560	13,239	13,737	11,372	10,878	10,546
Property, Plant & Equipment	7,294	7,209	6,198	6,010	6,355	6,434
Long-Term Investments	4,218	2,484	2,296	2,008	2,139	2,488
Goodwill	6,477	6,800	5,917	2,748	3,220	4,025
Other Intangible Assets	406	466	502	502	409	439
Long-Term Deferred Tax Assets	-	1,723	834	778	741	786
Long-Term Deferred Charges	-	-	-	-	1	2
Other Long-Term Assets	1	2	2	2	2	2
Total Assets	29,956	31,924	29,486	23,421	23,746	24,724
Accounts Payable	6,335	6,647	5,690	4,252	4,109	4,609
Accrued Expenses	39	893	903	805	708	699
Current Portion of Long-Term Debt	2,502	2,639	2,655	3,490	2,276	2,565
Current Portion of Leases	-	158	176	187	214	254
Current Income Taxes Payable	348	284	286	333	429	573
Other Current Liabilities	2,060	1,367	978	768	741	692
Total Current Liabilities	11,284	11,988	10,688	9,835	8,477	9,392
Long-Term Debt	9,869	11,053	9,654	5,216	7,085	7,432
Long-Term Leases	-	429	264	245	337	446
Pension & Post-Retirement Benefits	1,056	1,038	941	791	781	708
Other Long-Term Liabilities	914	500	499	349	368	416
Total Liabilities	23,123	25,008	22,046	16,436	17,048	18,394
Common Stock	1,961	1,961	1,961	1,298	1,274	1,251
Additional Paid-In Capital	2,091	2,186	2,177	1,553	1,529	1,476
Retained Earnings	2,890	2,938	3,530	4,014	3,811	3,494
Treasury Stock	-376	-471	-550	-210	-210	-208
Comprehensive Income & Other	248	253	242	225	203	207
Total Common Equity	6,814	6,867	7,360	6,880	6,607	6,220
Minority Interest	19	49	80	105	91	110
Shareholders' Equity	6,833	6,916	7,440	6,985	6,698	6,330
Total Liabilities & Equity	29,956	31,924	29,486	23,421	23,746	24,724
Total Debt	12,371	14,279	12,749	9,138	9,912	10,697
Net Cash (Debt)	-9,816	-9,368	-5,599	-4,396	-5,921	-6,093
Net Cash Per Share	-862.23	-827.45	-532.02	-352.52	-477.64	-492.49
Filing Date Shares Outstanding	11.5	11.36	11.24	9.43	9.35	9.29
Total Common Shares Outstanding	11.5	11.36	11.24	9.43	9.35	9.3
Working Capital	276	1,251	3,049	1,537	2,401	1,154
Book Value Per Share	592.39	604.44	654.62	729.93	706.43	668.98
Tangible Book Value	-69	-399	941	3,630	2,978	1,756
Tangible Book Value Per Share	-6.00	-35.12	83.69	385.12	318.41	188.86

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.